Industry Trend

Site Sections

Menu








© 2023. All Rights reserved.

Overview for SHIONOGI

All Data per May 25, 2023

Industry:

Drug Manufacturers—Specialty & Generic

Last Close:

6,172.00 JPY

Expected Dividend:

1.94 %

Payoffs per Year:

2
Business Summary
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. Its primary products Tivicay for HIV treatment; Mulpleta for the treatment of thrombocytopenia; Xofluza, an influenza drug; Symproic for opioid-induced constipation treatment; and Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment. The company also offers antibody detection kits for COVID-19. Shionogi & Co., Ltd. has collaboration agreements with InveniAI, LLC.; Hsiri Therapeutics Inc.; Nagasaki University; Roche Group to develop and commercialize Xofluza; and Nagasaki University and The Kitasato Institute to develop antimalarial drugs and vaccines. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.

Competitors View

Ordering

HIKMA PHARMACEUTICALS

GBR		 1.14 1.71%
3.23%		 11.39% 2.62% 1.0 0.44
-50.72%		 16.3 6.91% 48.04 1.0

SHIONOGI

JPN
 0.93 1.47%
1.94%		 11.11% 2.23% 1.0 2.26
-24.04%		 30.2 -14.63% 86.33 2.0

MERCK KGAA

GER		 0.95 1.18%
1.33%		 5.85% 1.4% 1.0 2.09
-27.25%		 18.37 13.71% 53.59 3.0

ZOETIS

USA		 1.08 0.66%
0.91%		 25.0% 1.94% 1.0 2.58
-39.95%		 20.45 3.46% 29.5 4.0

TAKEDA PHARMACEUTICAL

JPN		 1.08 4.1%
3.98%		 0.0% 3.76% -1.0 -0.04
-50.99%		 36.97 19.35% 43.13 5.0

EISAI

JPN		 1.01 2.08%
1.78%		 0.0% 1.91% 0.0 1.25
-23.18%		 41.03 -7.99% 62.25 6.0

DERMAPHARM

GER		 1.03 1.16%
5.74%		 4.02% 1.27% -0.5 0.54
-57.98%		 0.0 11.95% 35.53 7.0

PERRIGO COMPANY

USA		 0.97 1.22%
4.21%		 9.04% 1.68% 1.0 -0.41
-80.62%		 38.65 -26.13% 43.95 8.0

SUMITOMO DAINIPPON PHARMA

JPN		 0.85 0.9%
2.05%		 5.74% 1.06% 1.0 -0.11
-80.46%		 16.96 -12.0% 51.5 9.0

KANGMEI PHARMACEUTICAL

CHN		 1.02 0.04%
0.0%		 -18.13% 0.02% 0.0 -0.28
-90.16%		 12.42 -118.17% 62.09 10.0

Information for SHIONOGI

Yield Triangle

Dividend & Close

Dividend Close Div.-Yield
Year
2023 120.00 6,172.00 1.94
2022 120.00 6,586.00 1.82
2021 108.00 8,125.00 1.33
2020 106.00 5,635.00 1.88
2019 100.00 6,767.00 1.48
2018 88.00 6,271.00 1.40
2017 76.00 6,097.00 1.25
2016 68.00 5,599.00 1.21

Fundamentals

Chart